June 22, 2021
World Intellectual Property Review
The Supreme Court of the United States’ Arthrex decision determined that Patent Trial and Appeal Board (PTAB) Administrative Patent Judges (APJs) were unconstitutionally appointed. As a remedy, the Supreme Court handed power to the U.S. Patent and Trademark Office (USPTO) director to assess inter partes review (IPR) decisions. World IP Review interviewed Finnegan partner Derek McCorquindale for his thoughts on the decision.
Derek said, “The director’s authority is executive and remains circumscribed to allow the U.S. President to maintain adequate control, including the power of direct removal. Additionally, any review conducted by the director will still be subject to judicial review at the United States Court of Appeals for the Federal Circuit.”
Read “Arthrex: ‘Patents Have Become More Political’”
United States v. Arthrex, Arthrex v. Smith & Nephew , Supreme Court of the United States (SCOTUS), Patent Trial and Appeal Board (PTAB), administrative patent judge (APJ)
Commentary
April 11, 2024
Media Mention
Women in Business Law Americas Awards 2024: Three Finnegan Attorneys Shortlisted
April 7, 2024
Press Release
Finnegan and BMW Group Successfully Demolish Non-Practicing Entity NorthStar’s Efforts
April 3, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.